The three cases were 1 EBV+ case in which approximately 10% of cancer cells were positive for LAP (TGFβ1) and 2 EBV− cases in which approximately 50 and 20% of cancer cells expressed LAP (TGFβ1). The gene discussed is TGFB1; the disease is cancer.